Blar i Brage INN på emneord "farmakologi"
Viser treff 1-5 av 5
-
Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption – an individual-level prescription database study
(Journal article; Peer reviewed, 2007)BACKGROUND: A previous study has shown that variations in threshold and intensity (lipid goal attainment) of statins for primary prevention contribute to regional differences in overall consumption of statins in Norway. ... -
Kolesterolsenkende legemidler – en legemiddelepidemiologisk studie i Norge
(Chronicle, 2007)Cand.pharm. Ingeborg Hartz forsvarte 15. desember 2006 sin doktorgradsavhandling med tittelen «En legemiddelepidemiologisk studie av kolesterolsenkende legemidler i Norge» ved Avdeling for samfunnsfarmasi, Institutt for ... -
Utvikling av farmasøytens kliniske ferdigheter
(Conference object, 2003)I dette foredraget beskriver Ingeborg Hartz Bartnes hvordan farmasøyter kan utvikle sine kliniske ferdigheter med hensyn til å kunne tilby en pasientfokusert tjeneste i helsevesenet. Erfaringer fra hennes masterstudium ... -
Whom are we treating with lipid-lowering drugs? Are we following the guidelines? Evidence from a population-based study: the Tromsø study 2001
(Journal article; Peer reviewed, 2004)Abstract Objective: The beneficial effect of lipid-lowering drugs (LLDs) is well documented. Despite increasing sales of LLDs, little is known about what characterizes LLD users. Our objective was to describe LLD users ... -
Why do sales of lipid-lowering drugs vary between counties in Norway? Evidence from the OPPHED Health Study 2000 /2001
(Journal article; Peer reviewed, 2006)Objective. To study and compare plausible factors that might explain varying sales of lipid-lowering drugs (LLDs) in the two neighbouring counties of Hedmark and Oppland in Norway, with a similar age distribution, ...